Cargando…
Patient-derived xenograft (PDX) models: characteristics and points to consider for the process of establishment
Tumor research has largely relied on xenograft models created by the engraftment of cultured cell lines derived from tumor tissues into immunodeficient mice for in vivo studies. Like in vitro models, such models retain the ability of tumor cells to continuously proliferate, so they have been used to...
Autores principales: | Fujii, Etsuko, Kato, Atsuhiko, Suzuki, Masami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Toxicologic Pathology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396735/ https://www.ncbi.nlm.nih.gov/pubmed/32764840 http://dx.doi.org/10.1293/tox.2020-0007 |
Ejemplares similares
-
Therapeutic antibodies: their mechanisms of action and the pathological
findings they induce in toxicity studies
por: Suzuki, Masami, et al.
Publicado: (2015) -
Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models
por: Okada, Seiji, et al.
Publicado: (2019) -
The status of donor cancer tissues affects the fate of patient-derived
colorectal cancer xenografts in NOG mice
por: FUJII, Etsuko, et al.
Publicado: (2015) -
Characterization of the large‐scale Japanese patient‐derived xenograft (J‐PDX) library
por: Yagishita, Shigehiro, et al.
Publicado: (2021) -
Patient-derived xenograft (PDX) models, applications and challenges in cancer research
por: Abdolahi, Shahrokh, et al.
Publicado: (2022)